$ABBV
AbbVie Inc.

2022 Q4 Form 10-Q Financial Statement

#000155115222000045 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $15.12B $14.81B
YoY Change 1.58% 3.28%
Cost Of Revenue $4.134B $5.022B
YoY Change -3.41% 14.4%
Gross Profit $10.95B $9.790B
YoY Change 3.64% -1.63%
Gross Profit Margin 72.42% 66.1%
Selling, General & Admin $3.252B $3.304B
YoY Change 2.68% 7.17%
% of Gross Profit 29.7% 33.75%
Research & Development $1.781B $1.614B
YoY Change -1.71% -3.53%
% of Gross Profit 16.26% 16.49%
Depreciation & Amortization $2.157B $181.0M
YoY Change 8.99% -18.83%
% of Gross Profit 19.7% 1.85%
Operating Expenses $5.032B $4.918B
YoY Change 1.06% 3.41%
Operating Profit $5.919B $4.603B
YoY Change 5.94% 6.9%
Interest Expense -$516.0M $560.0M
YoY Change -12.1% -6.04%
% of Operating Profit -8.72% 12.17%
Other Income/Expense, Net -$2.021B $330.0M
YoY Change 835.65% -1671.43%
Pretax Income $2.965B $4.400B
YoY Change -30.58% 19.31%
Income Tax $493.0M $448.0M
% Of Pretax Income 16.63% 10.18%
Net Earnings $2.473B $3.949B
YoY Change -38.85% 24.22%
Net Earnings / Revenue 16.35% 26.66%
Basic Earnings Per Share $1.39 $2.22
Diluted Earnings Per Share $1.38 $2.21
COMMON SHARES
Basic Shares Outstanding 1.768B shares 1.768B shares
Diluted Shares Outstanding 1.776B shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.229B $11.88B
YoY Change -6.11% -3.02%
Cash & Equivalents $9.201B $11.83B
Short-Term Investments $28.00M $47.00M
Other Short-Term Assets $4.401B $4.570B
YoY Change -11.86% 5.47%
Inventory $3.579B $3.172B
Prepaid Expenses
Receivables $11.25B $10.74B
Other Receivables $0.00 $0.00
Total Short-Term Assets $28.46B $30.36B
YoY Change 1.92% 4.86%
LONG-TERM ASSETS
Property, Plant & Equipment $4.935B $4.893B
YoY Change -3.42% -4.62%
Goodwill $32.16B $31.73B
YoY Change -0.69% -1.76%
Intangibles $67.44B $68.73B
YoY Change -11.21% -11.27%
Long-Term Investments $241.0M $235.0M
YoY Change -13.0% -13.6%
Other Assets $5.571B $5.382B
YoY Change 14.07% 13.38%
Total Long-Term Assets $110.3B $111.0B
YoY Change -6.96% -7.46%
TOTAL ASSETS
Total Short-Term Assets $28.46B $30.36B
Total Long-Term Assets $110.3B $111.0B
Total Assets $138.8B $141.3B
YoY Change -5.27% -5.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.934B $23.51B
YoY Change 1.8% 7.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.000M $10.00M
YoY Change -92.86% -37.5%
Long-Term Debt Due $4.135B $9.197B
YoY Change -66.87% 38.18%
Total Short-Term Liabilities $29.54B $32.71B
YoY Change -16.07% 14.65%
LONG-TERM LIABILITIES
Long-Term Debt $59.14B $60.40B
YoY Change -7.87% -18.43%
Other Long-Term Liabilities $30.66B $30.22B
YoY Change 6.81% 3.84%
Total Long-Term Liabilities $30.66B $30.22B
YoY Change 6.81% 3.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.54B $32.71B
Total Long-Term Liabilities $30.66B $30.22B
Total Liabilities $60.19B $62.93B
YoY Change -5.79% 9.19%
SHAREHOLDERS EQUITY
Retained Earnings $4.784B $4.953B
YoY Change 52.99% 209.56%
Common Stock $19.25B $19.06B
YoY Change 5.14% 5.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.594B $4.590B
YoY Change 46.17% 51.99%
Treasury Stock Shares 44.59M shares 44.57M shares
Shareholders Equity $17.25B $15.99B
YoY Change
Total Liabilities & Shareholders Equity $138.8B $141.3B
YoY Change -5.27% -5.06%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $2.473B $3.949B
YoY Change -38.85% 24.22%
Depreciation, Depletion And Amortization $2.157B $181.0M
YoY Change 8.99% -18.83%
Cash From Operating Activities $7.428B $7.602B
YoY Change 46.36% -4.2%
INVESTING ACTIVITIES
Capital Expenditures $213.0M -$177.0M
YoY Change -213.9% -18.43%
Acquisitions
YoY Change
Other Investing Activities -$235.0M $1.463B
YoY Change -75.47% -467.59%
Cash From Investing Activities -$448.0M $1.286B
YoY Change -60.87% -309.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.634B -5.518B
YoY Change 52.0% 51.47%
NET CHANGE
Cash From Operating Activities 7.428B 7.602B
Cash From Investing Activities -448.0M 1.286B
Cash From Financing Activities -9.634B -5.518B
Net Change In Cash -2.654B 3.370B
YoY Change 10.22% -8.35%
FREE CASH FLOW
Cash From Operating Activities $7.428B $7.602B
Capital Expenditures $213.0M -$177.0M
Free Cash Flow $7.215B $7.779B
YoY Change 37.12% -4.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001551152
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35565
dei Entity Registrant Name
EntityRegistrantName
AbbVie Inc.
CY2022Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
40000000 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0375147
dei Entity Address Address Line1
EntityAddressAddressLine1
1 North Waukegan Road
dei Entity Address City Or Town
EntityAddressCityOrTown
North Chicago
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60064-6400
dei City Area Code
CityAreaCode
847
dei Local Phone Number
LocalPhoneNumber
932-7900
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1768480508 shares
CY2022Q3 us-gaap Revenues
Revenues
14812000000 usd
CY2021Q3 us-gaap Revenues
Revenues
14342000000 usd
us-gaap Revenues
Revenues
42933000000 usd
us-gaap Revenues
Revenues
41311000000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5022000000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4390000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13244000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13126000000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3304000000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3083000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11843000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9089000000 usd
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1614000000 usd
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1661000000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
4720000000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
5095000000 usd
CY2022Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
40000000 usd
CY2021Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
402000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
454000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
719000000 usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-229000000 usd
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-500000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-57000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-432000000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
10209000000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
10036000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
30318000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
28461000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4603000000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4306000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
12615000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
12850000000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-497000000 usd
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-585000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1568000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1813000000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-36000000 usd
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-12000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-108000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-35000000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
330000000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-427000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2284000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4400000000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3688000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10512000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8718000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
448000000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
508000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1139000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1214000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
3952000000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
3180000000 usd
us-gaap Profit Loss
ProfitLoss
9373000000 usd
us-gaap Profit Loss
ProfitLoss
7504000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000000 usd
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
10000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
3949000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3179000000 usd
us-gaap Net Income Loss
NetIncomeLoss
9363000000 usd
us-gaap Net Income Loss
NetIncomeLoss
7498000000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.22
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.21
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.21
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.19
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1771000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1770000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1771000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1769000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1776000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1777000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1777000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1776000000 shares
CY2022Q3 us-gaap Profit Loss
ProfitLoss
3952000000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
3180000000 usd
us-gaap Profit Loss
ProfitLoss
9373000000 usd
us-gaap Profit Loss
ProfitLoss
7504000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-11000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-30000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-8000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-32000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-989000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-361000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2043000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-794000000 usd
CY2022Q3 abbv Other Comprehensive Income Loss Net Investment Hedge Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
165000000 usd
abbv Other Comprehensive Income Loss Net Investment Hedge Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
348000000 usd
CY2021Q3 abbv Other Comprehensive Income Loss Net Investment Hedge Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
51000000 usd
abbv Other Comprehensive Income Loss Net Investment Hedge Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
123000000 usd
CY2022Q3 abbv Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
599000000 usd
CY2021Q3 abbv Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
184000000 usd
abbv Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
1265000000 usd
abbv Other Comprehensive Income Loss Net Investment Hedge Gain Loss After Reclassificationand Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
444000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-14000000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-35000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-17000000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-50000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-60000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-67000000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-136000000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-196000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
14000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
17000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
13000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
16000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
83000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
57000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
98000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
115000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-247000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-53000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-544000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3705000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3127000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8829000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7465000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
10000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3702000000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3126000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8819000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7459000000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11832000000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9746000000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
47000000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
84000000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10743000000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9977000000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
3172000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
3128000000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
4570000000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
4993000000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
30364000000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
27928000000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
235000000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
277000000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4893000000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5110000000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
68725000000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
75951000000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
31726000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
32379000000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5382000000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4884000000 usd
CY2022Q3 us-gaap Assets
Assets
141325000000 usd
CY2021Q4 us-gaap Assets
Assets
146529000000 usd
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
10000000 usd
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
14000000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
9197000000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
12481000000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
23505000000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22699000000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
32712000000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35194000000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
60399000000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
64189000000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1972000000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3009000000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30215000000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28701000000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
454000000 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1812973038 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1803195293 shares
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
18000000 usd
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
18000000 usd
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
44572117 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
34857597 shares
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4590000000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3143000000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19056000000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
18305000000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4953000000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3127000000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3443000000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2899000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
15994000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15408000000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
33000000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
28000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16027000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15436000000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
141325000000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
146529000000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12594000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3179000000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-53000000 usd
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2319000000 usd
CY2021Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
6000000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
180000000 usd
CY2021Q3 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
2000000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13577000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14688000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
3949000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-247000000 usd
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2512000000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4000000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
155000000 usd
CY2022Q3 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-2000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16027000000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13097000000 usd
us-gaap Net Income Loss
NetIncomeLoss
7498000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39000000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6953000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
803000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
771000000 usd
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
6000000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13577000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
15436000000 usd
us-gaap Net Income Loss
NetIncomeLoss
9363000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-544000000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7537000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1483000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
787000000 usd
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
5000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16027000000 usd
us-gaap Profit Loss
ProfitLoss
9373000000 usd
us-gaap Profit Loss
ProfitLoss
7504000000 usd
us-gaap Depreciation
Depreciation
582000000 usd
us-gaap Depreciation
Depreciation
630000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5728000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5912000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1415000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-153000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
647000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2447000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
539000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
563000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
454000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
719000000 usd
abbv Other Charges Related To Collaborations
OtherChargesRelatedToCollaborations
0 usd
abbv Other Charges Related To Collaborations
OtherChargesRelatedToCollaborations
500000000 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
172000000 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
68000000 usd
abbv Non Cash Litigation Reserve Adjustments Net Of Cash Payments
NonCashLitigationReserveAdjustmentsNetOfCashPayments
2261000000 usd
abbv Non Cash Litigation Reserve Adjustments Net Of Cash Payments
NonCashLitigationReserveAdjustmentsNetOfCashPayments
21000000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
770000000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
50000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
151000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
185000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1039000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
572000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
516000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
60000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
462000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
330000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1454000000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
184000000 usd
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-628000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17515000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17702000000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
494000000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
837000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
482000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
600000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1428000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
73000000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1460000000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
88000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-769000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-223000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-175000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1199000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2000000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1000000000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
7582000000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
5662000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
7537000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
6947000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1483000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
803000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
209000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
169000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
817000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
480000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
41000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
22000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15169000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12701000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-85000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-69000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2086000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3733000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9746000000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8449000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11832000000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12182000000 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
11000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
96000000 usd
CY2021Q3 abbv Reclassification Of Development Milestone Expense From Research And Development Expense
ReclassificationOfDevelopmentMilestoneExpenseFromResearchAndDevelopmentExpense
12000000 usd
CY2021Q3 abbv Reclassification Of Development Milestone Expense To Iprd And Milestones Expense
ReclassificationOfDevelopmentMilestoneExpenseToIPRDAndMilestonesExpense
12000000 usd
abbv Reclassification Of Development Milestone Expense From Research And Development Expense
ReclassificationOfDevelopmentMilestoneExpenseFromResearchAndDevelopmentExpense
162000000 usd
abbv Reclassification Of Development Milestone Expense To Iprd And Milestones Expense
ReclassificationOfDevelopmentMilestoneExpenseToIPRDAndMilestonesExpense
162000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
560000000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
596000000 usd
us-gaap Interest Expense
InterestExpense
1664000000 usd
us-gaap Interest Expense
InterestExpense
1843000000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
63000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
30000000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-497000000 usd
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-585000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1568000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1813000000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
903000000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
932000000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1309000000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1193000000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
960000000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1003000000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
3172000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
3128000000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10679000000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10727000000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5786000000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5617000000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4893000000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5110000000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
181000000 usd
us-gaap Depreciation
Depreciation
582000000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
223000000 usd
us-gaap Depreciation
Depreciation
630000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
3949000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3179000000 usd
us-gaap Net Income Loss
NetIncomeLoss
9363000000 usd
us-gaap Net Income Loss
NetIncomeLoss
7498000000 usd
CY2022Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
18000000 usd
CY2021Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
21000000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
43000000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
53000000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3931000000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3158000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9320000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7445000000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1771000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1770000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1771000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1769000000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.22
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.21
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
3949000000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3179000000 usd
us-gaap Net Income Loss
NetIncomeLoss
9363000000 usd
us-gaap Net Income Loss
NetIncomeLoss
7498000000 usd
CY2022Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
18000000 usd
CY2021Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
21000000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
43000000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
53000000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3931000000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3158000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9320000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7445000000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1771000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1770000000 shares
CY2021Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
402000000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1771000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1769000000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1776000000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1777000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1777000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1776000000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.21
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.19
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
494000000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
837000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
719000000 usd
CY2021Q3 abbv Additional Contribution To Collaboration By Partner
AdditionalContributionToCollaborationByPartner
500000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
32379000000 usd
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-653000000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
31726000000 usd
CY2022Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
95799000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27744000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68055000000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
97432000000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22151000000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
75281000000 usd
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
670000000 usd
CY2022Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
670000000 usd
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
670000000 usd
CY2021Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
670000000 usd
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
96469000000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27744000000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
68725000000 usd
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
98102000000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22151000000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
75951000000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5700000000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5900000000 usd
CY2022Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
770000000 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
0 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Fair Value Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
0 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet
0 usd
us-gaap Gain Loss From Components Excluded From Assessment Of Fair Value Hedge Effectiveness Net
GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
0 usd
CY2022Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
569000000 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
267000000 usd
CY2022Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
509000000 usd
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
37000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
14887000000 usd
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
12997000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-647000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2447000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
978000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
525000000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
14556000000 usd
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
14919000000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
143000000 usd
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
149000000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
126000000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
135000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
539000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
563000000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
25000000 usd
CY2021Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
27000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
102000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
101000000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
101000000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
108000000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
437000000 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
462000000 usd
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.30
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.30
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.30
CY2022Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1400000000 usd
us-gaap Revenues
Revenues
42933000000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.11
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.14
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.14
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
141000000 usd
CY2022Q3 us-gaap Revenues
Revenues
14812000000 usd
CY2021Q3 us-gaap Revenues
Revenues
14342000000 usd
us-gaap Revenues
Revenues
41311000000 usd

Files In Submission

Name View Source Status
0001551152-22-000045-index-headers.html Edgar Link pending
0001551152-22-000045-index.html Edgar Link pending
0001551152-22-000045.txt Edgar Link pending
0001551152-22-000045-xbrl.zip Edgar Link pending
abbv-20220930.htm Edgar Link pending
abbv-20220930.xsd Edgar Link pending
abbv-20220930xex311.htm Edgar Link pending
abbv-20220930xex312.htm Edgar Link pending
abbv-20220930xex321.htm Edgar Link pending
abbv-20220930xex322.htm Edgar Link pending
abbv-20220930_g1.jpg Edgar Link pending
abbv-20220930_g2.gif Edgar Link pending
abbv-2022930xex102.htm Edgar Link pending
abbv-2022930xex102001.jpg Edgar Link pending
abbv-2022930xex102002.jpg Edgar Link pending
abbv-2022930xex102003.jpg Edgar Link pending
abbv-2022930xex102004.jpg Edgar Link pending
abbv-2022930xex102005.jpg Edgar Link pending
abbv-2022930xex102006.jpg Edgar Link pending
abbv-2022930xex102007.jpg Edgar Link pending
abbv-2022930xex102008.jpg Edgar Link pending
abbv-2022930xex102009.jpg Edgar Link pending
abbv-2022930xex102010.jpg Edgar Link pending
abbv-2022930xex102011.jpg Edgar Link pending
abbv-2022930xex102012.jpg Edgar Link pending
abbv-2022930xex102013.jpg Edgar Link pending
abbv-2022930xex102014.jpg Edgar Link pending
abbv-2022930xex102015.jpg Edgar Link pending
abbv-2022930xex102016.jpg Edgar Link pending
abbv-2022930xex102017.jpg Edgar Link pending
abbv-2022930xex102018.jpg Edgar Link pending
abbv-2022930xex102019.jpg Edgar Link pending
abbv-2022930xex102020.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
abbv-20220930_cal.xml Edgar Link unprocessable
abbv-20220930_def.xml Edgar Link unprocessable
abbv-20220930_pre.xml Edgar Link unprocessable
abbv-20220930_lab.xml Edgar Link unprocessable
abbv-20220930_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable